This NIH grant is for developing in vivo preclinical assays to advance therapeutic development for mental illnesses.
SynopsisVersion HistoryRelated DocumentsPackage This grant, offered by the National Institutes of Health (NIH), aims to support the development of in vivo neurophysiological and behavioral measures in animal models. The primary purpose is to identify, optimize, and evaluate these measures for use as early screening assays in the therapeutic development pipeline for mental illnesses. By building on systems neurobiology and clinical neuroscience, the initiative seeks to establish robust surrogate markers of neural [...]